Literature DB >> 12062342

Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation.

Bianca J J M Brundel1, Jannie Ausma, Isabelle C van Gelder, Johan J L Van der Want, Wiek H van Gilst, Harry J G M Crijns, Robert H Henning.   

Abstract

OBJECTIVE: Atrial fibrillation (AF) is accompanied by electrical, structural and ion-channel protein remodeling. We tested if proteolysis by calpain and proteasome is activated during AF, and studied the relation with the remodeling processes.
METHODS: Right atrial appendages were obtained from patients with paroxysmal (n=7) or persistent (n=10) lone AF and compared to controls (n=10) in sinus rhythm undergoing coronary artery bypass grafting (CABG). Proteolysis was measured using Suc-Leu-Leu-Val-Tyr-7-amino-4-methyl-coumarin. Protein expression of calpain I and II was assessed by Western-blot and calpain I localization by immunohistochemistry. Structural changes were quantified by counting atrial myocytes with contraction bands or hibernation.
RESULTS: Calpain activity was significantly increased in paroxysmal AF (2-fold, P<0.001) and persistent AF (3-fold, P<0.001), mainly due to calpain I activation. Increased calpain I protein expression was found in AF with Western blot and immunohistochemistry. Myocytes from all AF groups showed increased contraction bands, whereas hibernation was only found in persistent AF. Calpain activity correlated with L-type Ca(2+) channel and Kv1.5 protein amounts (r=-0.80, P<0.001 and r=-0.72, P<0.001, respectively), degree of structural changes (r=0.90, P<0.001), shortening of atrial effective refractory period (AERP) (basic cycle length 500 ms, r=-0.60, P<0.001) and AERP rate adaptation (r=-0.80, P<0.001).
CONCLUSIONS: Calpain activity is induced during AF and correlates with parameters of ion-channel protein, structural and electrical remodeling. The results suggest that calpain activation represents an important mechanism linking calcium overload to cellular adaptation mechanisms in human AF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12062342     DOI: 10.1016/s0008-6363(02)00289-4

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  33 in total

1.  Ankyrin-B protein in heart failure: identification of a new component of metazoan cardioprotection.

Authors:  Farshid Kashef; Jingdong Li; Patrick Wright; Jedidiah Snyder; Faroug Suliman; Ahmet Kilic; Robert S D Higgins; Mark E Anderson; Philip F Binkley; Thomas J Hund; Peter J Mohler
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

Review 2.  Atrial fibrillation: basic mechanisms, remodeling and triggers.

Authors:  Akiko Shiroshita-Takeshita; Bianca J J M Brundel; Stanley Nattel
Journal:  J Interv Card Electrophysiol       Date:  2005-09       Impact factor: 1.900

Review 3.  Different subcellular populations of L-type Ca2+ channels exhibit unique regulation and functional roles in cardiomyocytes.

Authors:  Jabe M Best; Timothy J Kamp
Journal:  J Mol Cell Cardiol       Date:  2011-08-23       Impact factor: 5.000

Review 4.  Proteostasis in cardiac health and disease.

Authors:  Robert H Henning; Bianca J J M Brundel
Journal:  Nat Rev Cardiol       Date:  2017-06-29       Impact factor: 32.419

5.  Role for myosin-V motor proteins in the selective delivery of Kv channel isoforms to the membrane surface of cardiac myocytes.

Authors:  Sarah M Schumacher-Bass; Eileen D Vesely; Lian Zhang; Katherine E Ryland; Dyke P McEwen; Priscilla J Chan; Chad R Frasier; Jeremy C McIntyre; Robin M Shaw; Jeffrey R Martens
Journal:  Circ Res       Date:  2014-02-07       Impact factor: 17.367

Review 6.  Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation.

Authors:  Stanley Nattel; Dobromir Dobrev
Journal:  Nat Rev Cardiol       Date:  2016-08-04       Impact factor: 32.419

Review 7.  Neuro-atriomyodegenerative origin of atrial fibrillation and superimposed conventional risk factors: continued search to configure the genuine etiology of "eternal arrhythmia".

Authors:  Petras Stirbys
Journal:  J Atr Fibrillation       Date:  2016-12-31

8.  Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing.

Authors:  J Zhao; J Li; W Li; Y Li; H Shan; Y Gong; B Yang
Journal:  Br J Pharmacol       Date:  2010-01-15       Impact factor: 8.739

Review 9.  Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target.

Authors:  Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-09-26       Impact factor: 3.000

10.  Pathology-specific effects of the IKur/Ito/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation.

Authors:  T Christ; E Wettwer; N Voigt; O Hála; S Radicke; K Matschke; A Várro; D Dobrev; U Ravens
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.